Journal of Ethnopharmacology 2012-01-06

Renoprotective potential of Macrothelypteris torresiana via ameliorating oxidative stress and proinflammatory cytokines.

Jinglou Chen, Yongfang Lei, Guanghua Wu, Yonghui Zhang, Wei Fu, Chaomei Xiong, Jinlan Ruan

Index: J. Ethnopharmacol. 139(1) , 207-13, (2012)

Full Text: HTML

Abstract

Macrothelypteris torresiana is traditionally used in Chinese folk medicine for the treatment of edema for patients suffering from kidney/bladder problems due to its satisfactory therapeutic effectiveness.The aim of this study was to investigate the renoprotective nature of the total polyphenols fraction from Macrothelypteris torresiana (PMT).The biochemical criterions of plasma and kidney tissues were evaluated to study the effects of PMT on puromycin aminonucleoside-induced chronic nephrotic syndrome (NS) in hyperlipidemic mice.In this study, the NS and hyperlipidemia were ameliorated after 9 weeks administration of PMT. Besides, PMT was able to modulate the level of renal oxidative stress and vascular endothelial growth factor-nitric oxide (VEGF-NO) pathway.It represented a potential resource of PMT for the treatment of NS involved in metabolic syndrome.Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Related Compounds

  • Stylomycin aminonu...

Related Articles:

Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats.

2015-02-01

[J. Appl. Toxicol. 35(2) , 165-72, (2014)]

Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation.

2015-01-01

[Sci. Rep. 5 , 17694, (2015)]

Fluvastatin attenuated the effect of expression of β1 integrin in PAN-treated podocytes by inhibiting reactive oxygen species.

2015-01-01

[Mol. Cell Biochem. 398(1-2) , 207-15, (2014)]

Sialic acid attenuates puromycin aminonucleoside-induced desialylation and oxidative stress in human podocytes.

2014-01-15

[Exp. Cell Res. 320(2) , 258-68, (2014)]

Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway.

2009-07-01

[J. Virol. 83 , 6739-47, (2009)]

More Articles...